0000000000303660

AUTHOR

Erik Fung

showing 2 related works from this author

Towards early risk biomarkers: serum metabolic signature in childhood predicts cardio-metabolic risk in adulthood

2021

Summary: Background: Cardiovascular diseases may originate in childhood. Biomarkers identifying individuals with increased risk for disease are needed to support early detection and to optimise prevention strategies. Methods: In this prospective study, by applying a machine learning to high throughput NMR-based metabolomics data, we identified circulating childhood metabolic predictors of adult cardiovascular disease risk (MetS score) in a cohort of 396 females, followed from childhood (mean age 11·2 years) to early adulthood (mean age 18·1 years). The results obtained from the discovery cohort were validated in a large longitudinal birth cohort of females and males followed from puberty to…

MaleGerontologyMedicine (General)Longitudinal studyApolipoprotein BbiomarkkeritDiseaseType 2 diabetesRisk FactorsInformed consentProspective StudiesChildProspective cohort studyFinlandmedia_commonFramingham Risk ScorebiologyRriskitekijätGeneral MedicineALSPACmetabolomicsaikuisuusCardiovascular DiseasesCohortMedicineBirth CohortFemaleResearch Papermedicine.medical_specialtyAdolescentlongitudinal-studypitkittäistutkimusGeneral Biochemistry Genetics and Molecular BiologyR5-920childrencardio-metabolic riskInternal medicinemedicineHumansmedia_common.cataloged_instanceEuropean unionApolipoproteins AApolipoproteins Bbusiness.industryPubertyCardio metabolic risklapsuusmedicine.diseaseCross-Sectional StudiesDiabetes Mellitus Type 2biology.proteinsydän- ja verisuonitauditaineenvaihduntatuotteetbusinessBiomarkersDeclaration of HelsinkieBioMedicine
researchProduct

Comorbidities, Fragility, and Quality of Life in Heart Failure Patients With Midrange Ejection Fraction.

2018

Objective: To assess the effects of comorbidities, fragility, and quality of life (QOL) on long-term prognosis in ambulatory patients with heart failure (HF) with midrange left ventricular ejection fraction (HFmrEF), an unexplored area. Patients and Methods: Consecutive patients prospectively evaluated at an HF clinic between August 1, 2001, and December 31, 2015, were retrospectively analyzed on the basis of left ventricular ejection fraction category. We compared patients with HFmrEF (n=185) to those with reduced (HFrEF; n=1058) and preserved (HFpEF; n=162) ejection fraction. Fragility was defined as 1 or more abnormal evaluations on 4 standardized geriatric scales (Barthel Index, Older A…

medicine.medical_specialtylcsh:R5-920Ejection fractionbusiness.industryDepression scaleComorbidity score030204 cardiovascular system & hematologymedicine.disease03 medical and health sciences0302 clinical medicineFragilityQuality of lifeHeart failureInternal medicineAmbulatoryCardiologyMedicineGeriatric Depression Scale030212 general & internal medicinebusinesslcsh:Medicine (General)Mayo Clinic proceedings. Innovations, qualityoutcomes
researchProduct